Displaying 7 (all) recruiting clinical trials.
-
A PHASE 1 STUDY OF TJ033721 IN SUBJECTS WITH ADVANCED OR METASTATIC SOLID TUMORS.
You can participate in this study if you are diagnosed with advanced solid tumors. The purpose of this study is to test the safety of ...Phase
Interventional
-
Compassionate Use of Pirtobrutinib for a Patient with Waldenstrom s macroglobulinemia.
You can participate in this study if you are diagnosed with Waldenstrom’s macroglobulinemia. In this study we will evaluate the study drug (Pirtobrutinib) for ...
Phase N/A Interventional
-
A Phase 1/2 Open-label Study to Investigate the Safety Efficacy and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults with Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
This study is designed for patients diagnosed with relapsed or refractory B cell precursor acute lymphoblastic leukemia (R/R B-ALL).
This study is a 2-part ...
Phase
Interventional
-
Test Age group both International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
-
Test Age group both International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
-
Test Age group both International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
-
Test New Study Notification
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
